Latest Breaking News On - Aaron waxman - Page 3 : comparemela.com

Winrevair: FDA approves new drug that may help stop and even reverse PAH

When doctors told Katrina Barry that she had a rare and serious condition called pulmonary arterial hypertension, or PAH, they warned her not to Google it.

FDA Approves Merck's WINREVAIR, a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension

WINREVAIR on top of background therapy significantly improved exercise capacity and multiple important secondary outcome measures compared to background therapy alone

Sotatercept's FDA Approval a New Chapter for Pulmonary Arterial Hypertension

Biologic should arrive on pharmacy shelves before May

First-in-class biologic approved for rare lung disease

FDA OKs First-in-Class Sotatercept for PAH

Sotatercept with background therapy significantly improved exercise capacity and multiple secondary outcome measures compared to background therapy alone in the STELLAR trial.